Filing Details

Accession Number:
0001765581-22-000047
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-11 17:29:53
Reporting Period:
2022-05-09
Accepted Time:
2022-05-11 17:29:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1784606 Patricia Carr 5Th Fl, Waterloo Exchange
Waterloo Rd
Dublin 4 L2
Svp, Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2022-05-09 1,056 $148.93 7,240 No 4 S Direct
Ordinary Shares Disposition 2022-05-09 11 $150.49 7,229 No 4 S Direct
Ordinary Shares Disposition 2022-05-10 273 $144.18 6,956 No 4 S Direct
Ordinary Shares Disposition 2022-05-11 722 $147.51 6,234 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  2. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.92 to $149.91 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.11 to $144.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  4. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $147.51 to $147.65. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.